SCHEMBL18280341

SCHEMBL18280341

COc1ccc(C(=O)O)c(OC)c1CCl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
ALDH1A1 P00352 3/20 0.44
HTT P42858 1/20 0.44
APEX1 P27695 1/20 0.43
PDE4D Q08499 2/20 0.43
MRGPRX4 Q96LA9 1/20 0.42
CDC25B P30305 1/20 0.42
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42
KDM4E B2RXH2 3/20 0.40
HPGD P15428 2/20 0.40
MYC P01106 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13607855 0.85 MAPT (0.57) MAPTTDP1ALDH1A1HTTAPEX1
SCHEMBL18280365 0.83 MAPT (0.56) MAPTTDP1ALDH1A1HTTAPEX1
SCHEMBL102827 0.78 MAPT (0.72) MAPTTDP1ALDH1A1HTTAPEX1
SCHEMBL28781948 0.78 SMN1; SMN2 (0.39) MAPTTDP1ALDH1A1HTTPDE4D
Benzene SCHEMBL27688092 0.77 MAPT (0.70) MAPTTDP1ALDH1A1HTTAPEX1
Water SCHEMBL9749470 0.77 MAPT (0.70) MAPTTDP1ALDH1A1HTTAPEX1
SCHEMBL27341170 0.77 MAPT (0.70) MAPTTDP1ALDH1A1HTTAPEX1
Hydrochloric Acid SCHEMBL5061862 0.77 MAPT (0.70) MAPTTDP1ALDH1A1HTTAPEX1
SCHEMBL4234764 0.75 MAPT (0.46) MAPTTDP1ALDH1A1PDE4DKDM4E
SCHEMBL1505827 0.75 TDP1 (0.61) MAPTTDP1ALDH1A1HTTCDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3303415-B1 VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF ALCON INC (CH) 2022-12-28 EP disclosed
US-10324311-B2 Visible-light photoinitiators and uses thereof NOVARTIS AG (CH) 2019-06-18 US disclosed
EP-3303415-A1 VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF Novartis AG (CH) 2018-04-11 EP disclosed
WO-2016193912-A1 VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF NOVARTIS AG (CH) 2016-12-08 WO disclosed
US-20160357031-A1 VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF ALCON INC. (CH) 2016-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10324311-B2 Visible-light photoinitiators and uses thereof SIRT5, IK, IGLV6-57 MAPT 145/4885TDP1 4374/4885ALDH1A1 1953/4885
US-20160357031-A1 VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF SIRT5, IK, IGLV6-57 MAPT 145/4885TDP1 4374/4885ALDH1A1 1953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.